Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Long-term Potentiation01:25

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when presynaptic neurons...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The long term prophylaxis of affective disorders.

Advances in biochemical psychopharmacology·1995
Same author

[Lithium and sensory analysis].

L'Encephale·1989
Same author

Different treatment modalities for recurrent bipolar affective disorders: an integrative approach.

Psychotherapy and psychosomatics·1986
Same author

Psychoactive drugs and stimulus analysis: IV. The experimental discrimination of acute and prophylactic antidepressants.

The International journal of neuroscience·1983
Same author

Psychoactive drugs and stimulus analysis: VI. Evaluation of one-trial modification of exploration as a basis for psychoactive drug classification.

The International journal of neuroscience·1983
Same author

Psychoactive drugs and stimulus analysis: I. The theoretical background and a model of affective disorders.

The International journal of neuroscience·1983
Same journal

Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Mitochondrial dysfunction in schizophrenia and its modulation by atypical antipsychotic drugs: A randomized controlled trial.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Effects of pimavanserin, xanomeline and highly-purified plant-derived cannabidiol on MK-801-induced behaviours in mice relevant to psychosis.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Pharmacokinetics and pharmacodynamics of orally administered S-ketamine in healthy participants.

Journal of psychopharmacology (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: May 25, 2026

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

The evolution of lithium therapy.

F N Johnson1

  • 1Department of Psychology, University of Lancaster, Fylde College, Bailrigg, Lancaster LA1 4YF, UK.

Journal of Psychopharmacology (Oxford, England)
|February 1, 2012
PubMed
Summary
This summary is machine-generated.

Lithium therapy for mania and depression has evolved, becoming safer with monitored serum levels. Lower doses and intermittent treatment reduce side effects while maintaining efficacy.

More Related Videos

Three-electrode Coin Cell Preparation and Electrodeposition Analytics for Lithium-ion Batteries
10:41

Three-electrode Coin Cell Preparation and Electrodeposition Analytics for Lithium-ion Batteries

Published on: May 22, 2018

Related Experiment Videos

Last Updated: May 25, 2026

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

Three-electrode Coin Cell Preparation and Electrodeposition Analytics for Lithium-ion Batteries
10:41

Three-electrode Coin Cell Preparation and Electrodeposition Analytics for Lithium-ion Batteries

Published on: May 22, 2018

Area of Science:

  • Psychiatry and Pharmacology
  • Neuroscience

Background:

  • Lithium's historical use in treating mood disorders.
  • Early challenges with lithium toxicity and current safety profiles.
  • Ongoing research into lithium's mechanism of action.

Purpose of the Study:

  • To describe the evolution of lithium therapy for mania and depression.
  • To highlight advancements in lithium's safety and efficacy.
  • To discuss current and potential applications of lithium treatment.

Main Methods:

  • Review of historical data and clinical studies on lithium therapy.
  • Analysis of biochemical models for lithium's mechanism of action.
  • Examination of recent therapeutic strategies, including lower doses and intermittent administration.

Main Results:

  • Lithium is now a safe medication when serum levels are monitored.
  • Lower doses and intermittent dosing (every second day) reduce side effects.
  • Lithium augmentation shows rapid antidepressant effects and prevents relapse.

Conclusions:

  • Lithium therapy has evolved into a safe and effective treatment for mood disorders.
  • Optimized dosing strategies enhance lithium's therapeutic index.
  • Lithium holds potential for broader clinical applications beyond psychiatry.